Iestyn M Shapey
Overview
Explore the profile of Iestyn M Shapey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shapey I, Alfred J, Sharp R, Whelan P, Szatmary P, Mann K, et al.
HPB (Oxford)
. 2024 May;
26(8):1075-1078.
PMID: 38762354
No abstract available.
2.
Shapey I, Summers A, OSullivan J, Fullwood C, Hanley N, Casey J, et al.
Diabetes Obes Metab
. 2023 Aug;
25(12):3529-3537.
PMID: 37646197
Background: Donor hyperglycaemia following brain death has been attributed to reversible insulin resistance. However, our islet and pancreas transplant data suggest that other mechanisms may be predominant. We aimed to...
3.
Shapey I, Summers A, Khambalia H, Yiannoullou P, Fullwood C, Hanley N, et al.
Diabetologia
. 2021 Jun;
64(9):2124-2125.
PMID: 34173017
No abstract available.
4.
Shapey I, Summers A, Khambalia H, Yiannoullou P, Fullwood C, Hanley N, et al.
Diabetologia
. 2021 Mar;
64(6):1375-1384.
PMID: 33665687
Aims/hypothesis: Approximately 50% of organ donors develop hyperglycaemia in intensive care, which is managed with insulin therapy. We aimed to determine the relationships between donor insulin use (DIU) and graft...
5.
Konstantinou I, Shapey I, Papamichael D, de Liguori Carino N
Eur J Surg Oncol
. 2020 Nov;
47(3 Pt A):591-596.
PMID: 33213959
Older age represents a major risk factor for developing colorectal cancer and the disease disproportionately affects patients older than 60 years of age. However, knowledge regarding the optimal management of...
6.
Shapey I, Tan Z, Gioco R, Khambalia H, Fullwood C, Yiannoullou P, et al.
Diabetes Obes Metab
. 2020 Sep;
23(1):49-57.
PMID: 32893472
Aims: The relationship between peri-transplant glycaemic control and outcomes following pancreas transplantation is unknown. We aimed to relate peri-transplant glycaemic control to pancreas graft survival and to develop a framework...
7.
Shapey I, Malik H, de Liguori Carino N
Eur J Surg Oncol
. 2020 Jul;
47(3 Pt A):576-582.
PMID: 32600896
Older age is a risk factor for the development of HCC. However, the treatment options available for older patients with HCC, their safety, efficacy and utility, are poorly understood resulting...
8.
Shapey I, Summers A, Yiannoullou P, Khambalia H, Fullwood C, Hanley N, et al.
Diabetes Obes Metab
. 2020 May;
22(10):1874-1879.
PMID: 32452110
Insulin is routinely used to manage hyperglycaemia in organ donors and during the peri-transplant period in islet transplant recipients. However, it is unknown whether donor insulin use (DIU) predicts beta-cell...
9.
Shapey I, Summers A, Yiannoullou P, Bannard-Smith J, Augustine T, Rutter M, et al.
Diabetes Obes Metab
. 2019 Mar;
21(7):1521-1528.
PMID: 30924574
Hyperglycaemia is common in hospitalized individuals, and is often caused by physiological stress associated with critical illness or major surgery. Insulin therapy is an established treatment for hyperglycaemia and acute...
10.
Yiannoullou P, Summers A, Goh S, Fullwood C, Khambalia H, Moinuddin Z, et al.
Diabetes Care
. 2019 Feb;
42(4):665-673.
PMID: 30765431
Objective: People with type 1 diabetes and kidney failure have an increased risk for major adverse cardiovascular events (MACE). Simultaneous pancreas and kidney transplantation (SPKT) improves survival, but the long-term...